ID   PLEA1_NIDPL             Reviewed;          69 AA.
AC   A8DY01; A8DY00; A8DY02; A8DY03; A8DY04; A8DY09; A8DY10; A8DY15;
DT   15-JAN-2008, integrated into UniProtKB/Swiss-Prot.
DT   13-NOV-2007, sequence version 1.
DT   25-MAY-2022, entry version 29.
DE   RecName: Full=Pleurain-A1;
DE   Flags: Precursor;
OS   Nidirana pleuraden (Yunnan pond frog) (Babina pleuraden).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Amphibia;
OC   Batrachia; Anura; Neobatrachia; Ranoidea; Ranidae; Nidirana.
OX   NCBI_TaxID=369511;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 44-69, FUNCTION,
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, MASS SPECTROMETRY, AND VARIANT
RP   SER-7.
RC   TISSUE=Skin, and Skin secretion;
RX   PubMed=17764786; DOI=10.1016/j.peptides.2007.07.020;
RA   Wang X., Song Y., Li J., Liu H., Xu X., Lai R., Zhang K.;
RT   "A new family of antimicrobial peptides from skin secretions of Rana
RT   pleuraden.";
RL   Peptides 28:2069-2074(2007).
CC   -!- FUNCTION: Antimicrobial peptide. Has activity against the Gram-positive
CC       bacterium S.aureus ATCC2592 (MIC=15 ug/ml), the Gram-negative bacteria
CC       E.coli ATCC25922 (MIC=60 ug/ml), B.dysenteriae (MIC=120 ug/ml),
CC       H.pylori NTCT11637 (MIC=30 ug/ml), and the fungus C.albicans ATCC2002
CC       (MIC=30 ug/ml). Has little hemolytic activity on rabbit red blood
CC       cells. {ECO:0000269|PubMed:17764786}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:17764786}.
CC   -!- TISSUE SPECIFICITY: Expressed by the skin glands.
CC       {ECO:0000269|PubMed:17764786}.
CC   -!- MASS SPECTROMETRY: Mass=3048.5; Method=MALDI;
CC       Evidence={ECO:0000269|PubMed:17764786};
CC   -!- SIMILARITY: Belongs to the frog skin active peptide (FSAP) family.
CC       Pleurain subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; EF613243; ABU88478.1; -; mRNA.
DR   EMBL; EF613244; ABU88479.1; -; mRNA.
DR   EMBL; EF613245; ABU88480.1; -; mRNA.
DR   EMBL; EF613246; ABU88481.1; -; mRNA.
DR   EMBL; EF613247; ABU88482.1; -; mRNA.
DR   EMBL; EF613248; ABU88483.1; -; mRNA.
DR   EMBL; EF613249; ABU88484.1; -; mRNA.
DR   EMBL; EF613250; ABU88485.1; -; mRNA.
DR   EMBL; EF613251; ABU88486.1; -; mRNA.
DR   EMBL; EF613252; ABU88487.1; -; mRNA.
DR   EMBL; EF613253; ABU88488.1; -; mRNA.
DR   EMBL; EF613254; ABU88489.1; -; mRNA.
DR   EMBL; EF613255; ABU88490.1; -; mRNA.
DR   EMBL; EF613256; ABU88491.1; -; mRNA.
DR   EMBL; EF613257; ABU88492.1; -; mRNA.
DR   EMBL; EF613258; ABU88493.1; -; mRNA.
DR   EMBL; EF613259; ABU88494.1; -; mRNA.
DR   AlphaFoldDB; A8DY01; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW.
DR   GO; GO:0044179; P:hemolysis in another organism; IEA:UniProtKB-KW.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR004275; Frog_antimicrobial_propeptide.
DR   Pfam; PF03032; FSAP_sig_propep; 1.
PE   1: Evidence at protein level;
KW   Amphibian defense peptide; Antibiotic; Antimicrobial;
KW   Cleavage on pair of basic residues; Cytolysis; Direct protein sequencing;
KW   Disulfide bond; Hemolysis; Secreted; Signal.
FT   SIGNAL          1..18
FT                   /evidence="ECO:0000255"
FT   PROPEP          19..43
FT                   /evidence="ECO:0000269|PubMed:17764786"
FT                   /id="PRO_0000313998"
FT   PEPTIDE         44..69
FT                   /note="Pleurain-A1"
FT                   /id="PRO_0000313999"
FT   DISULFID        63..69
FT   VARIANT         7
FT                   /note="T -> S"
FT                   /evidence="ECO:0000269|PubMed:17764786"
FT   CONFLICT        3
FT                   /note="T -> P (in Ref. 1; ABU88487)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        7
FT                   /note="T -> I (in Ref. 1; ABU88481)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        9
FT                   /note="L -> S (in Ref. 1; ABU88478)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        13
FT                   /note="F -> V (in Ref. 1; ABU88493)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        22
FT                   /note="C -> R (in Ref. 1; ABU88493)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        26
FT                   /note="R -> G (in Ref. 1; ABU88482)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        27
FT                   /note="D -> V (in Ref. 1; ABU88488)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        33
FT                   /note="G -> E (in Ref. 1; ABU88493)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   69 AA;  8086 MW;  E6193B39CA38482F CRC64;
     MFTLKKTLLL LFFLGTISIS LCKQERDADE DDGRKMTEEE VKRSIITMTK EAKLPQLWKQ
     IACRLYNTC